Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclosporine--lessons from the first 20 years.

R Cortesini1

  • 1Columbia University Department of Pathology, New York, NY 10032, USA. rc238@columbia.edu

Transplantation Proceedings
|March 26, 2004
PubMed
Summary

Cyclosporine significantly improved long-term graft survival rates in organ transplantation. However, due to its nephrotoxicity, personalized immunosuppression using immunologic tests is now advocated to minimize drug use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.

Transplant immunology·2007
Same author

Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

The organizational model of the interregional transplant agency Organizzazione Centro-Sud Trapianti.

Transplantation proceedings·2005
Same author

Transplantation activity in the Organizzazione Centro-Sud Trapianti: a retrospective study from 1999 to March 2004.

Transplantation proceedings·2005
Same author

Organizzazione Centro-Sud Trapianti: outcome analysis 1999 to 2002.

Transplantation proceedings·2004
Same author

Road to transplantation tolerance: role of T-suppressor lymphocytes in solid-organ transplantation.

Transplantation proceedings·2002

Area of Science:

  • Transplantation immunology
  • Nephrology
  • Immunosuppressive therapy

Background:

  • Cyclosporine revolutionized organ transplantation, dramatically increasing long-term graft survival rates.
  • Pre-cyclosporine era graft survival rates at 5, 10, and 20 years were 35%, 22%, and 20% respectively.
  • Post-cyclosporine era survival rates improved significantly to 75%, 60%, and 45% at the same time points.

Purpose of the Study:

  • To highlight the impact of cyclosporine on graft survival.
  • To address the nephrotoxicity associated with calcineurin inhibitors like cyclosporine.
  • To advocate for a shift towards tailored immunosuppression strategies.

Main Methods:

  • Review of historical graft survival data from the pre-cyclosporine and cyclosporine eras.
  • Discussion of the nephrotoxic side effects of calcineurin inhibitors.
  • Proposal of utilizing immunologic tests for personalized immunosuppression.

Main Results:

  • Cyclosporine-based immunosuppression markedly enhanced long-term graft survival.
  • Nephrotoxicity remains a significant concern with calcineurin inhibitors.
  • Immunologic testing allows for quantitative and qualitative assessment of immune cells.

Conclusions:

  • While cyclosporine improved transplant outcomes, its nephrotoxicity necessitates alternative strategies.
  • Tailoring immunosuppression based on immunologic monitoring can reduce drug exposure.
  • Minimizing immunosuppression through personalized approaches is crucial for long-term patient and graft health.

Related Experiment Videos